Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival - Wikidata - awgldk - TriplyDB

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

http://www.wikidata.org/entity/Q37326199

about

Surgical and molecular pathology of pancreatic neoplasms Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas Pancreatic insulinomas: Laparoscopic management Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management Update on surgical treatment of pancreatic neuroendocrine neoplasms Cancer concepts and principles: primer for the interventional oncologist-part II Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?Neuroendocrine pancreatic tumors: guidelines for management and update Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target.Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Concomitant endometrial and pancreatic cancers.Hereditary pancreatic cancer: related syndromes and clinical perspective.Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report.Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution.Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients.Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D.Clinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from iran Co-existence of insulinoma and diabetes: A case report KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review.Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.Glucagonoma-induced acute heart failure.Update on pancreatic neuroendocrine tumors.Practical management and treatment of pancreatic neuroendocrine tumors.Rare and unusual endocrine cancer syndromes with mutated genes.Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.

P2860

Q26748615-C6029047-B930-482D-98F4-A1C9643820DB Q26752757-A046D638-8787-486A-97D7-726A508BE2A7 Q26777226-1FB2875A-33D3-483A-8287-F489A20EF042 Q26795597-E4558E8D-71D1-45D5-A0E4-6E771B21DC6F Q26864361-B01631F6-5EBF-487C-A30E-674A0CDEACBB Q27010961-F77EB490-371E-42A0-A386-FC5C5FF80196 Q28078610-ED8BE0F1-0574-43DF-A9F8-7AE7789652AA Q28078948-E080C0D9-8C66-4ABC-9793-6C18D22341D5 Q28256132-EE2966D7-F551-4568-A307-E737E575704B Q28392577-1F73DC31-226F-4C70-9609-6DAE0D7C99FB Q30252766-245FD3E5-B487-4F4D-AA04-A138369F6E9D Q33573118-EB131111-B5FD-410D-8217-D2DDC2AB3FA6 Q33606047-EBE7A3EF-9111-4AE2-8715-EF4FEA90A6E8 Q33672117-9BCACE8C-EEDB-43A3-B95E-1AACAEE7836C Q33737587-C5058986-CC8D-48C7-8450-A7099E9511E6 Q33763759-70B78577-F901-400C-89EF-4136DF892E16 Q33851085-4803B7A7-7CDD-49F4-B194-545F169EBA34 Q33879711-8499E4C2-65B7-4F48-8160-0ACAD6EF20E6 Q33892438-3BA1EBD1-213A-4A13-A9CE-4190181EF1EB Q33925601-86F0D7CB-663A-409C-9E30-DDFF66A601EA Q33947995-E34FFDB6-F471-4775-AED1-EA27C35506A0 Q33993022-E9F86E16-ED65-4E3D-AC8A-4185384001AD Q34141433-96A7FCA4-405E-40A9-8C9E-0CF4F298E3FB Q34157801-3FAA532D-C24B-4B52-BD51-A1B0441D616E Q34245961-3C78D6B9-2B28-4402-99F4-4A785017EF80 Q34248466-B6683C9A-CD69-4EBD-BFBD-CBE12F60C3D9 Q34248487-F9DE7F9D-4E98-48C0-947F-EE1EB4F1DA2B Q34301030-25B6F733-2FB5-474F-823D-486023D70210 Q34400151-73B70DB2-80E6-485D-A06F-F2C3FB53BF3D Q34446086-D6727815-E369-41E8-83FC-B8AB2369E805 Q34448100-00E51486-FB3D-47A0-8CCC-10E690AC38E5 Q34453043-7338E1C6-2C81-421D-BAFC-EDE28EB857B0 Q34573600-F9B4B6CF-0281-4E0C-BFB6-5883E65F338C Q34645240-E0D4E055-F82D-45EE-BBC0-2A1B62215C51 Q34702075-0EBB734E-D3F9-431C-B084-381923A22E49 Q34713663-E18CE339-DBDE-470C-A0FE-B57204EE3343 Q34750730-FC3A6247-DD10-40F5-B9FE-A68A543F409A Q34832999-1DC7E746-52FC-4437-8D88-5268CBB2C4C9 Q35015049-39274DEA-B7C3-441D-8BA3-A5D6AF53721D Q35034000-85D7E157-C4A5-4AD5-A707-3EEF27559462

P2860

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

http://www.wikidata.org/entity/Q37326199

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pancreatic neuroendocrine tumo ...... trend toward improved survival

@en

Pancreatic neuroendocrine tumo ...... rend toward improved survival.

@nl

type

label

Pancreatic neuroendocrine tumo ...... trend toward improved survival

@en

Pancreatic neuroendocrine tumo ...... rend toward improved survival.

@nl

prefLabel

Pancreatic neuroendocrine tumo ...... trend toward improved survival

@en

Pancreatic neuroendocrine tumo ...... rend toward improved survival.

@nl

P1433

Q37326199-74C03D14-63BA-4C58-886B-244B09B84FEE

P1476

Q37326199-A8AF8202-3702-4CE3-A82C-5E8783F33C30

P2093

Q37326199-21157402-C1EC-45B0-811F-47859E20DB35

Q37326199-33065B98-31FF-4C9E-A7E0-C404B9586CC2

Q37326199-BF8061BA-9CC7-411D-A9B0-D5C4D58D1CBA

Q37326199-FC5C86C0-9A94-4EFB-AFEB-E2641B6F61BA

P2860

Q37326199-0C933F4C-4F44-4D43-8D9B-50E10D718515

Q37326199-0E62A83E-2072-48C7-B3CD-3D6B032DCB92

Q37326199-2058BCCA-2526-43E2-9284-688A28A7C19D

Q37326199-41801197-AEA1-441A-BC49-1C33FA3301B8

Q37326199-50936901-6569-4AB5-B71E-538AFE628B2D

Q37326199-599098C0-24CB-428A-B680-BD80DA9CEEF7

Q37326199-5D74B777-EFC3-4124-90D7-4FA85CE7DCDF

Q37326199-71EFF542-4D4B-48D7-9511-3FAEA7C83C51

Q37326199-873B4451-DEC8-4AC4-AC8B-EB5BDA17B4E5

Q37326199-916A81BC-EA7B-427E-9BF1-A21C791037AC

P304

Q37326199-34334F52-77E0-430B-A3B8-9A230FAA30FB

P31

Q37326199-828C7993-C8B5-4AEB-8554-DFFCDEF75CE9

P356

Q37326199-DFF0365A-945A-4470-AAF9-0F68854E7743

P433

Q37326199-F795D298-1FA1-4C62-A70D-37AAF1508834

P478

Q37326199-14EEFF37-7926-43BC-ADCF-3BC208E48D38

P577

Q37326199-DC3D38B9-0DBA-4106-B11F-CBA361504B6C

P5875

Q37326199-E1C4C657-9807-4BBB-8623-E9F57BC8CB27

P698

Q37326199-464AF5B2-7ABC-41C8-8394-CE491202F2C1

P921

Q37326199-4A4D6F99-7F75-4A88-98A5-B492AE73A169

P932

Q37326199-7159D4C9-1A17-48B5-8645-5891A14DF6EF

P356

P1433

Annals of Oncology

P1476

Pancreatic neuroendocrine tumo ...... trend toward improved survival

@en

P2093

G M Petersen

http://www.w3.org/2001/XMLSchema#string

J Rubin

http://www.w3.org/2001/XMLSchema#string

K G Rabe

http://www.w3.org/2001/XMLSchema#string

T R Halfdanarson

http://www.w3.org/2001/XMLSchema#string

P2860

Rationale for the use of somatostatin analogs as antitumor agents

Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases

Hepatic surgery for metastases from neuroendocrine tumors.

Incidence and management of malignant digestive endocrine tumours in a well defined French population.

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.

Endocrine tumours of the gastrointestinal tract. Biotherapy for metastatic endocrine tumours.

Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material.

Islet cell carcinoma of the pancreas.

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.

Liver, gallbladder, extrahepatic bile ducts, and pancreas.

P304

1727-1733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDN351

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5329755

http://www.w3.org/2001/XMLSchema#string

P698

18515795

http://www.w3.org/2001/XMLSchema#string

P921

neuroendocrinology

P932

2735065

http://www.w3.org/2001/XMLSchema#string